← Back to home

HER2-LOW UNRESECTABLE/METASTATIC BREAST CANCER COMPLICATED WITH VISCERAL CRISIS

Clinical trials for HER2-LOW UNRESECTABLE/METASTATIC BREAST CANCER COMPLICATED WITH VISCERAL CRISIS explained in plain language.

Never miss a new study

Get alerted when new HER2-LOW UNRESECTABLE/METASTATIC BREAST CANCER COMPLICATED WITH VISCERAL CRISIS trials appear

Sign up with your email to follow new studies for HER2-LOW UNRESECTABLE/METASTATIC BREAST CANCER COMPLICATED WITH VISCERAL CRISIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for breast cancer patients in critical condition

Disease control Recruiting now

This study is testing if a new drug called Trastuzumab Rezetecan (SHR-A1811) works better than standard chemotherapy for people with a severe form of advanced breast cancer. It is for patients whose cancer has spread and is causing rapid organ failure, a life-threatening situatio…

Matched conditions: HER2-LOW UNRESECTABLE/METASTATIC BREAST CANCER COMPLICATED WITH VISCERAL CRISIS

Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

HER2-LOW UNRESECTABLE/METASTATIC BREAST CANCER COMPLICATED WITH VISCERAL CRISIS

Get alerted when new HER2-LOW UNRESECTABLE/METASTATIC BREAST CANCER COMPLICATED WITH VISCERAL CRISIS trials appear

New hope for breast cancer patients in critical condition